Table 1 Demographic data and disease characteristics of all participants categorised into walking exercise and usual-care groups (N=111)

From: Effect of walking on circadian rhythms and sleep quality of patients with lung cancer: a randomised controlled trial

 

Walking exercise group

n =56

Usual-care group

n =55

P a

Age (years)

Mean (SD)

64.64 (11.54)

62.51 (9.64)

0.284

Median

67.00

62.00

 

Range

37–83

40–81

 

Education (years)

Mean (SD)

10.71 (4.77)

10.71 (4.45)

0.995

Sex (n, %)

Male

24 (42.9)

25 (45.5)

0.783

Female

32 (57.1)

30 (54.5)

 

Employed (n, %)

No

40 (71.4)

31 (56.4)

0.988

Yes

16 (28.6)

24 (43.6)

 

Marital status (n, %)

Married

46 (82.1)

45 (81.8)

0.965

Unmarried

10 (17.9)

10 (18.2)

 

Cancer stage (n, %) b

1

34 (60.8)

38 (69.1)

0.355

2

5 (8.9)

4 (7.3)

 

3

5 (8.9)

5 (9.0)

 

4

5 (8.9)

4 (7.3)

 

Unknown

7 (12.5)

4 (7.3)

 

Treatment status (n, %)

On treatment

37 (66.1)

39 (70.9)

0.583

Off treatment

19 (33.9)

16 (29.1)

 

Current treatment (n, %) c

Surgery

30 (81.1)

31 (79.5)

0.861

Radiotherapy

2 (5.4)

2 (5.1)

 

Target therapy

3 (8.1)

5 (12.8)

 

Chemoradiotherapy

2 (5.4)

1 (2.6)

 

Days since diagnosis

Mean (SD)

451.06 (636.82)

456.53 (812.50)

0.969

Median

103.50

112.00

 

Range

7–2493

12–3465

 
  1. aP values are based on the chi-square test for categorical variables and the t test for continuous variables.
  2. bIn the chi-square test, cancer stages 2, 3, 4, and unknown were merged in one cell for comparison with cancer stage 1 to follow the statistical assumption and treat fewer than five cells. We present data from each original cell here for clarity.
  3. cIn the chi-square test, radiotherapy, target therapy, and chemoradiotherapy were merged in one cell for comparison with surgery to follow the statistical assumption and treat fewer than five cells. We present data from each original cell here for clarity.
Back to article page